These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22791367)

  • 41. Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells.
    Subramanian C; Kovatch KJ; Sim MW; Wang G; Prince ME; Carey TE; Davis R; Blagg BSJ; Cohen MS
    Neoplasia; 2017 Dec; 19(12):1003-1011. PubMed ID: 29121598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. AFF4 promotes tumorigenesis and tumor-initiation capacity of head and neck squamous cell carcinoma cells by regulating SOX2.
    Deng P; Wang J; Zhang X; Wu X; Ji N; Li J; Zhou M; Jiang L; Zeng X; Chen Q
    Carcinogenesis; 2018 Jul; 39(7):937-947. PubMed ID: 29741610
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells.
    Krishnamurthy S; Warner KA; Dong Z; Imai A; Nör C; Ward BB; Helman JI; Taichman RS; Bellile EL; McCauley LK; Polverini PJ; Prince ME; Wicha MS; Nör JE
    Stem Cells; 2014 Nov; 32(11):2845-57. PubMed ID: 25078284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
    Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
    Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of FaDu-R, a radioresistant head and neck cancer cell line, and cancer stem cells.
    Cho KJ; Park EJ; Kim MS; Joo YH
    Auris Nasus Larynx; 2018 Jun; 45(3):566-573. PubMed ID: 28844650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer stem cells in head and neck squamous cell carcinoma.
    Szafarowski T; Szczepanski MJ
    Otolaryngol Pol; 2014; 68(3):105-11. PubMed ID: 24837904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nicotine promotes acquisition of stem cell and epithelial-to-mesenchymal properties in head and neck squamous cell carcinoma.
    Yu MA; Kiang A; Wang-Rodriguez J; Rahimy E; Haas M; Yu V; Ellies LG; Chen J; Fan JB; Brumund KT; Weisman RA; Ongkeko WM
    PLoS One; 2012; 7(12):e51967. PubMed ID: 23300583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ADAM17-mediated CD44 cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCC.
    Kamarajan P; Shin JM; Qian X; Matte B; Zhu JY; Kapila YL
    Cancer Med; 2013 Dec; 2(6):793-802. PubMed ID: 24403253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma.
    Chen C; Wei Y; Hummel M; Hoffmann TK; Gross M; Kaufmann AM; Albers AE
    PLoS One; 2011 Jan; 6(1):e16466. PubMed ID: 21304586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of marker-defined HNSCC subpopulations reveals a dynamic regulation of tumor initiating properties.
    Bragado P; Estrada Y; Sosa MS; Avivar-Valderas A; Cannan D; Genden E; Teng M; Ranganathan AC; Wen HC; Kapoor A; Bernstein E; Aguirre-Ghiso JA
    PLoS One; 2012; 7(1):e29974. PubMed ID: 22276135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
    Lo WL; Yu CC; Chiou GY; Chen YW; Huang PI; Chien CS; Tseng LM; Chu PY; Lu KH; Chang KW; Kao SY; Chiou SH
    J Pathol; 2011 Mar; 223(4):482-95. PubMed ID: 21294122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolation and genomic characterization of stem cells in head and neck cancer.
    Wilson GD; Marples B; Galoforo S; Geddes TJ; Thibodeau BJ; Grénman R; Akervall J
    Head Neck; 2013 Nov; 35(11):1573-82. PubMed ID: 23108794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD44+ cancer cell-induced metastasis: A feasible neck metastasis model.
    Wu TF; Chen L; Bu LL; Gao J; Zhang WF; Jia J
    Eur J Pharm Sci; 2017 Apr; 101():243-250. PubMed ID: 28215944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer.
    Sayed SI; Dwivedi RC; Katna R; Garg A; Pathak KA; Nutting CM; Rhys-Evans P; Harrington KJ; Kazi R
    Oral Oncol; 2011 Apr; 47(4):237-43. PubMed ID: 21382740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stem cell profiling in head and neck cancer reveals an Oct-4 expressing subpopulation with properties of chemoresistance.
    Reers S; Pfannerstill AC; Maushagen R; Pries R; Wollenberg B
    Oral Oncol; 2014 Mar; 50(3):155-62. PubMed ID: 24387977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apigenin inhibited hypoxia induced stem cell marker expression in a head and neck squamous cell carcinoma cell line.
    Ketkaew Y; Osathanon T; Pavasant P; Sooampon S
    Arch Oral Biol; 2017 Feb; 74():69-74. PubMed ID: 27886571
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Attenuation of cancer-initiating cells stemness properties by abrogating S100A4 calcium binding ability in head and neck cancers.
    Cheng LH; Hung KF; Huang TF; Hsieh HP; Wang SY; Huang CY; Lo JF
    Oncotarget; 2016 Nov; 7(48):78946-78957. PubMed ID: 27793047
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolation and Characterization of Cancer Stem Cells from Primary Head and Neck Squamous Cell Carcinoma Tumors.
    Kim HS; Pearson AT; Nör JE
    Methods Mol Biol; 2016; 1395():241-9. PubMed ID: 26910078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt.
    Kuo SZ; Blair KJ; Rahimy E; Kiang A; Abhold E; Fan JB; Wang-Rodriguez J; Altuna X; Ongkeko WM
    BMC Cancer; 2012 Nov; 12():556. PubMed ID: 23176396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers.
    Lo JF; Yu CC; Chiou SH; Huang CY; Jan CI; Lin SC; Liu CJ; Hu WY; Yu YH
    Cancer Res; 2011 Mar; 71(5):1912-23. PubMed ID: 21169409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.